KRYSTAL BIOTECH ($KRYS) posted quarterly earnings results on Tuesday, May 6th. The company reported earnings of $1.20 per share, missing estimates of $1.39 by $0.19. The company also reported revenue of $88,180,000, missing estimates of $98,167,288 by $-9,987,288.
You can see Quiver Quantitative's $KRYS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KRYSTAL BIOTECH Insider Trading Activity
KRYSTAL BIOTECH insiders have traded $KRYS stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.
Here’s a breakdown of recent trading of $KRYS stock by insiders over the last 6 months:
- KRISH S KRISHNAN (President and CEO) has made 0 purchases and 27 sales selling 100,000 shares for an estimated $17,129,547.
- SUMA KRISHNAN (President, R&D) has made 0 purchases and 27 sales selling 100,000 shares for an estimated $17,129,547.
- KATHRYN ROMANO (Chief Accounting Officer) sold 750 shares for an estimated $131,415
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KRYSTAL BIOTECH Hedge Fund Activity
We have seen 131 institutional investors add shares of KRYSTAL BIOTECH stock to their portfolio, and 153 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JENNISON ASSOCIATES LLC removed 269,927 shares (-88.9%) from their portfolio in Q1 2025, for an estimated $48,667,838
- NORGES BANK added 208,188 shares (+1835.9%) to their portfolio in Q4 2024, for an estimated $32,614,732
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 200,000 shares (-20.2%) from their portfolio in Q4 2024, for an estimated $31,332,000
- STATE STREET CORP removed 173,836 shares (-12.0%) from their portfolio in Q4 2024, for an estimated $27,233,147
- SOLEUS CAPITAL MANAGEMENT, L.P. added 141,400 shares (+65.2%) to their portfolio in Q4 2024, for an estimated $22,151,724
- BLACKROCK, INC. removed 90,707 shares (-2.2%) from their portfolio in Q1 2025, for an estimated $16,354,472
- INVESCO LTD. removed 90,356 shares (-24.7%) from their portfolio in Q4 2024, for an estimated $14,155,170
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KRYSTAL BIOTECH Analyst Ratings
Wall Street analysts have issued reports on $KRYS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 12/18/2024
To track analyst ratings and price targets for KRYSTAL BIOTECH, check out Quiver Quantitative's $KRYS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
